Mingrui Ge - Search Results

Year	Number of Results
2005	2
2006	1
2008	1
2009	1
2010	3
2011	7
2012	7
2013	2
2014	7
2015	13
2016	11
2017	14
2018	14
2019	7
2020	13
2021	17
2022	27
2023	24
2024	10

1

CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment.

Pan Z, Xu T, Bao L, Hu X, Jin T, Chen J, Chen J, Qian Y, Lu X, Li L, Zheng G, Zhang Y, Zou X, Song F, Zheng C, Jiang L, Wang J, Tan Z, Huang P, Ge M. Pan Z, et al. Among authors: ge m. Mol Cancer. 2022 Oct 3;21(1):190. doi: 10.1186/s12943-022-01658-x. Mol Cancer. 2022. PMID: 36192735 Free PMC article.

2

Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.

Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators. Hadoux J, et al. N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870969 Clinical Trial.

3

Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy.

Liu Y, Wang J, Hu X, Pan Z, Xu T, Xu J, Jiang L, Huang P, Zhang Y, Ge M. Liu Y, et al. Among authors: ge m. Drug Resist Updat. 2023 May;68:100939. doi: 10.1016/j.drup.2023.100939. Epub 2023 Feb 8. Drug Resist Updat. 2023. PMID: 36806005 Free article. Review.

4

Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities.

Zhang L, Feng Q, Wang J, Tan Z, Li Q, Ge M. Zhang L, et al. Among authors: ge m. Biochim Biophys Acta Rev Cancer. 2023 Jul;1878(4):188928. doi: 10.1016/j.bbcan.2023.188928. Epub 2023 May 29. Biochim Biophys Acta Rev Cancer. 2023. PMID: 37257629 Free article. Review.

5

Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway.

Hu Y, Wen Q, Cai Y, Liu Y, Ma W, Li Q, Song F, Guo Y, Zhu L, Ge J, Zeng Q, Wang J, Yin C, Zheng G, Ge M. Hu Y, et al. Among authors: ge m. Phytomedicine. 2023 Jan;108:154528. doi: 10.1016/j.phymed.2022.154528. Epub 2022 Oct 27. Phytomedicine. 2023. PMID: 36343549

6

ISG15 and ISGylation modulates cancer stem cell-like characteristics in promoting tumor growth of anaplastic thyroid carcinoma.

Xu T, Zhu C, Chen J, Song F, Ren X, Wang S, Yi X, Zhang Y, Zhang W, Hu Q, Qin H, Liu Y, Zhang S, Tan Z, Pan Z, Huang P, Ge M. Xu T, et al. Among authors: ge m. J Exp Clin Cancer Res. 2023 Jul 27;42(1):182. doi: 10.1186/s13046-023-02751-9. J Exp Clin Cancer Res. 2023. PMID: 37501099 Free PMC article.

7

Targeting one-carbon metabolism for cancer immunotherapy.

Ren X, Wang X, Zheng G, Wang S, Wang Q, Yuan M, Xu T, Xu J, Huang P, Ge M. Ren X, et al. Among authors: ge m. Clin Transl Med. 2024 Jan;14(1):e1521. doi: 10.1002/ctm2.1521. Clin Transl Med. 2024. PMID: 38279895 Free PMC article. Review.

8

COVID-19 instigates adipose browning and atrophy through VEGF in small mammals.

Jing X, Wu J, Dong C, Gao J, Seki T, Kim C, Urgard E, Hosaka K, Yang Y, Long S, Huang P, Zheng J, Szekely L, Zhang Y, Tao W, Coquet J, Ge M, Chen Y, Adner M, Cao Y. Jing X, et al. Among authors: ge m. Nat Metab. 2022 Dec;4(12):1674-1683. doi: 10.1038/s42255-022-00697-4. Epub 2022 Dec 8. Nat Metab. 2022. PMID: 36482111 Free PMC article.

9

KRAS mutation-driven angiopoietin 2 bestows anti-VEGF resistance in epithelial carcinomas.

Hosaka K, Andersson P, Wu J, He X, Du Q, Jing X, Seki T, Gao J, Zhang Y, Sun X, Huang P, Yang Y, Ge M, Cao Y. Hosaka K, et al. Among authors: ge m. Proc Natl Acad Sci U S A. 2023 Jul 18;120(29):e2303740120. doi: 10.1073/pnas.2303740120. Epub 2023 Jul 10. Proc Natl Acad Sci U S A. 2023. PMID: 37428914 Free PMC article.

10

Autophagic blockade potentiates anlotinib-mediated ferroptosis in anaplastic thyroid cancer.

Wu J, Liang J, Liu R, Lv T, Fu K, Jiang L, Ma W, Pan Y, Tan Z, Liu Q, Qiu W, Ge M, Wang J. Wu J, et al. Among authors: ge m. Endocr Relat Cancer. 2023 Aug 1;30(9):e230036. doi: 10.1530/ERC-23-0036. Print 2023 Sep 1. Endocr Relat Cancer. 2023. PMID: 37283515 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

163 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Results by year